Association of ataxin-7 with the proteasome subunit S4 of the 19S regulatory complex

Human Molecular Genetics

Volumn 10, Issue 24, 2001, Pages 2821-2831

  Matilla, Antoni ^a,e   Gorbea, Carlos ^b   Einum, David D ^b   Townsend, Jeannette ^b   Michalik, Andrej ^d   Van Broeckhoven, Christine ^d   Jensen, Christopher C ^a   Murphy, Kelley J ^c   Ptácek, Louis J ^a,b   Fu, Ying Hui ^b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ATAXIN 7; GENE PRODUCT; POLYGLUTAMINE; PROTEASOME; PROTEIN SUBUNIT; UBIQUITIN; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; ARTICLE; BRAIN DEGENERATION; CELL NUCLEUS; CEREBELLUM; COMPLEX FORMATION; CONTROLLED STUDY; GENE FUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SPINOCEREBELLAR DEGENERATION; TWO HYBRID SYSTEM;

ANIMALIA; EPICOCCUM;

EID: 0035891863     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/10.24.2821     Document Type: Article

References (60)

1. Autosomal dominant cerebellar ataxia with retinal degeneration: Clinical, neuropathologic, and genetic analysis of a large kindred
2. On an autosomal dominant form of retinal-cerebellar degeneration: An autopsy study of five patients in one family
3. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion
4. Expansion of an unstable trinucleotide (CAG) repeat in spinocerebellar ataxia type 1
5. Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats
6. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2
7. Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT
8. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1
9. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α 1A-voltage-dependent calcium channel
10. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein
11. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
12. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
13. Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA)
14. Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p
15. Spinocerebellar ataxia type 7 (SCA7): A neurodegenerative disorder with neuronal intranuclear inclusions
16. Identification and localization of ataxin-7 in brain and retina of a patient with cerebellar ataxia type II using anti-peptide antibody
17. Expanded polyglutamines induce neurodegeneration and trans-neuronal alterations in cerebellum and retina of SCA7 transgenic mice
18. Cause of neural death in neurodegenerative diseases attributable to expansion of glutamine repeats
19. Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: Correlation between the density of inclusions and IT15 CAG triplet repeat length
20. Ataxin-1 nuclear localization and aggregation: Role in polyglutamine-induced disease in SCA1 transgenic mice
21. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions
22. Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice
23. Interaction of expanded polyglutamine stretches with nuclear transcription factors leads to aberrant transcriptional regulation in polyglutamine diseases
24. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity
25. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures
26. Chaperone suppression of aggregation and altered subcellular proteasone localization imply protein misfolding in SCA1
27. Evidence for proteasome involvement in polyglutamine disease: Localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro
28. Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone
29. Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins
30. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice
31. Distribution of ataxin-7 in normal human brain and retina
32. Conserved phosphoprotein interaction motif is functionally interchangeable between ataxin-7 and arrestins
33. Ataxin-7 expression analysis in controls and spinocerebellar ataxia type 7 patients
34. Interferon γ regulates accumulation of the proteasome activator PA28 and immunoproteasomes at nuclear PML bodies
35. The ubiquitin-proteasome pathway: On protein death and cell life
36. The 26S proteasome
37. The proteasome, a novel protease regulated by multiple mechanisms
38. Localization of the 26S proteasome during mitosis and meiosis in fission yeast
39. Mts4, a non-ATPase subunit of the 26 S protease in fission yeast is essential for mitosis and interacts directly with the ATPase subunit Mts2
40. Intracellular targeting of the proteasome
41. Retinoic acid regulates aberrant nuclear localization of PML-RAR α in acute promyelocytic leukemia cells
42. Expression analysis of ataxin-7 mRNA and protein in human brain: Evidence for a widespread distribution and focal protein accumulation
43. Activation of the cell death program by inhibition of proteasome function
44. The role of the ubiquitin-proteasome pathway in apoptosis
45. Proteasomes in apoptosis: Villains or guardians?
46. Proteasomes and proteasome inhibition in the central nervous system
47. Proteasome inhibitor PS519 reduces infarction and attenuates leukocyte infiltration in a rat model of focal cerebral ischemia
48. Involvement of the proteasome in the programmed cell death of NGF-deprived sympathetic neurons
49. Inducible expression of mutant α-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis
50. Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington's disease
51. Intragenic deletion in the gene encoding ubiquitin C-terminal hydrolase in gad mice
52. Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia
53. Defective mitosis due to a mutation in the gene for a fission yeast 26S protease subunit
54. Active site mutants in the six regulatory particle ATPases reveal multiple roles for ATP in the proteasome
55. Recognition of misfolding proteins by PA700, the regulatory subcomplex of the 26 S proteasome
56. The base of the proteasome regulatory particle exhibits chaperone-like activity
57. AAA+: A class of chaperone-like ATPases associated with the assembly, operation, and disassembly of protein complexes
58. The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1
59. Mapping subunit contacts in the regulatory complex of the 26 S proteasome. S2 and S5b form a tetramer with ATPase subunits S4 and S7